vimarsana.com

Page 10 - ஹோல்டிங்ஸ் ஒன்றுபட்டது மாநிலங்களில் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CLS Holdings USA, Inc Announces Amendments to Additional Convertible Debentures

CLS Holdings USA, Inc. Announces Amendments to Additional Convertible Debentures LAS VEGAS, NV / ACCESSWIRE / April 22, 2021 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), the Company or CLS , a diversified cannabis company operating as Cannabis Life Sciences, today announced that it has amended the terms of $6,229,672 in principal amount, which includes capitalized interest, of its outstanding unsecured convertible debentures (the U.S. Debentures ) issued October 25, 2018 and October 31, 2018 by, among other things, (i) reducing the conversion price from $0.80 per unit to $0.30 per unit; and (ii) extending the maturity date of the U.S. Debentures by one year to four (4) years from the execution date of the U.S. Debentures. The exercise price of the warrants issuable upon conversion of the U.S. Debentures remains unchanged. The amendments also provide that the Company shall file a registration statement to register for resale all of the shares of common stock of the Company

CLS Holdings USA, Inc : A Joint Venture: CLS Branded Division, City Trees, Partners with Renowned Nevada Cultivator in Exclusive Collaboration

(0) LAS VEGAS, NV / ACCCESSWIRE / April 20, 2021 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), the Company or CLS , a diversified cannabis company operating as Cannabis Life Sciences, today announced the development of an exclusive line of collaboration products through its branded wholesale division, City Trees. The brand has secured an agreement with renowned Nevada cannabis cultivator, Nature s Chemistry, to produce a co-branded line of cured and live resin concentrate products, for release commencing in April 2021. In its second fully co-branded collaboration project, City Trees will be producing cured and live resin products made exclusively from Nature s Chemistry high quality input material, starting with 5,000 units of cured concentrate. The project has been structured as an equal net revenue split, and will be sold collaboratively by both entities to encourage rapid sell-through and expanded market penetration. With this highly anticipated release generating exciteme

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.